NorthRock Partners LLC Acquires 532 Shares of Abbott Laboratories (NYSE:ABT)
NorthRock Partners LLC boosted its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 3.5% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 15,684 shares of the healthcare product maker’s stock after purchasing an additional 532 shares during the period. NorthRock […]
More Stories
Centessa Pharmaceuticals plc (NASDAQ:CNTA) Insider Gregory M. Weinhoff Sells 10,000 Shares
Centessa Pharmaceuticals plc (NASDAQ:CNTA – Get Free Report) insider Gregory M. Weinhoff sold 10,000 shares of the firm’s stock in...
Analysts Set Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Price Target at $166.00
Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Free Report) have earned an average recommendation of “Moderate Buy” from the...
Applied Materials, Inc. (NASDAQ:AMAT) Given Average Recommendation of “Moderate Buy” by Analysts
Applied Materials, Inc. (NASDAQ:AMAT – Get Free Report) has been given an average rating of “Moderate Buy” by the twenty-two...
Quest Resource Holding Co. (NASDAQ:QRHC) Director Glenn Culpepper Buys 2,000 Shares
Quest Resource Holding Co. (NASDAQ:QRHC – Get Free Report) Director Glenn Culpepper bought 2,000 shares of the company’s stock in...
Insider Selling: Nektar Therapeutics (NASDAQ:NKTR) Insider Sells 33,402 Shares of Stock
Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) insider Mark Andrew Wilson sold 33,402 shares of the company’s stock in a...
Insider Selling: Impinj, Inc. (NASDAQ:PI) COO Sells 826 Shares of Stock
Impinj, Inc. (NASDAQ:PI – Get Free Report) COO Hussein Mecklai sold 826 shares of Impinj stock in a transaction on...